Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Improved detection of gastrointestinal pathogens using generalised sample processing and amplification panels

Siah, Shoo Peng1; Merif, Juan2; Kaur, Kiran1; Nair, Jiny1; Huntington, Peter G.4; Karagiannis, Thomas4; Stark, Damien5; Rawlinson, William3; Olma, Tom6; Thomas, Lee6; Melki, John R.1; Millar, Douglas S.1

Pathology - Journal of the RCPA: January 2014 - Volume 46 - Issue 1 - p 53–59
doi: 10.1097/PAT.0000000000000022

Summary: We aimed to streamline the diagnosis of gastrointestinal disease by producing multiplexed real time polymerase chain reaction (PCR) panels employing universal sample processing for DNA and RNA containing pathogens.

A total of 487 stored, previously characterised stool samples comprising bacterial, viral, protozoan and Clostridium difficile positive samples were tested using four multiplexed real time PCR panels. A further 81 pre-selected clinical samples from a teaching hospital were included to provide an independent validation of assay performance.

Improved sensitivity was achieved using the protozoan panels and 16 more mixed infections were observed compared to tests with conventional methods. Using the C. difficile panels, 100% sensitivity was achieved when compared to the gold standard of toxigenic culture. In addition, hypervirulent strains including ribotype 027 could be identified directly from primary sample without the need for ribotyping methods. Bacterial and viral panels detecting Salmonella, Shigella, Campylobacter, Yersinia enterocolitica, Listeria monocytogenes, norovirus groups I and II, rotavirus A, astrovirus, sapovirus, rotavirus B, adenovirus and adenovirus 40/41 performed as well as conventional methods, whilst allowing detection in 3 hours from processing to result.

Multiplex real time PCR panels with universal sample preparation allow streamlined, rapid diagnosis of gastrointestinal pathogens whilst extending the characterisation of pathogens present in stool samples from affected patients.

1Genetic Signatures, c/o Virology Research Laboratories, Prince of Wales Hospital, Randwick

2Microbiology Division, SEALS, Prince of Wales Hospital, Randwick

3Virology Division, SEALS Microbiology, Prince of Wales, Randwick

4Department of Microbiology & Infectious Diseases, Pacific Laboratory Medicine Services, Royal North Shore Hospital, St Leonards

5Microbiology Department, St Vincent's Hospital, Darlinghurst

6General Microbiology, CIDMLS, Institute of Clinical Pathology and Medical Research, Westmead, NSW, Australia

Address for correspondence: Dr D. Millar, Genetic Signatures, c/o Virology Research Laboratories, Level 3 Clinical Sciences Building, Prince of Wales Hospital, Randwick, NSW 2031, Australia. E-mail:

Received 18 January, 2013

Revised 23 October, 2013

Accepted 23 October, 2013

© 2014 Royal College of Pathologists of Australasia
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website